Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glabellar Lines”

148 trials

Showing 20 of 148 results

Not applicableActive Not RecruitingNCT07398755
What this trial is testing

Prospective, Non-interventional Study Assessing Periorbital Rejuvenation Procedure

Who this might be right for
Glabellar LinesMidface Volume DeficiencyPeriorbital Wrinkling
Yuvell 34
Large-scale testing (Phase 3)Study completedNCT02450526
What this trial is testing

Dysport in the Treatment of Glabellar Lines in Chinese Subjects

Who this might be right for
Glabellar Lines
Ipsen 520
Testing effectiveness (Phase 2)Active Not RecruitingNCT07321834
What this trial is testing

Evaluate AI-09 In Participants With Glabellar Lines

Who this might be right for
Glabellar Lines
Eirion Therapeutics Inc. 68
Large-scale testing (Phase 3)Study completedNCT05380154
What this trial is testing

Efficacy and Safety Assessment of Botulax® and BOTOX® for Improvement of Glabellar Lines.

Who this might be right for
Glabellar Lines
Hugel 500
Large-scale testing (Phase 3)Study completedNCT00777803
What this trial is testing

NT 201 (Xeomin®/Bocouture®) in Comparison With Clostridium Botulinum Toxin Type A in the Treatment of Glabellar Frown Lines

Who this might be right for
Glabellar Frown Lines
Merz Pharmaceuticals GmbH 381
Testing effectiveness (Phase 2)Study completedNCT01485601
What this trial is testing

Safety and Efficacy Study of Botulinum Toxin Type A to Treat Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Medy-Tox 121
Large-scale testing (Phase 3)Study completedNCT00430963
What this trial is testing

IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines

Who this might be right for
Glabellar Frown Lines
Merz Pharmaceuticals GmbH 256
Post-approval studies (Phase 4)Study completedNCT01391312
What this trial is testing

Patient Satisfaction Study of BOTOX® Cosmetic in the Treatment of Moderate to Severe Frown Lines

Who this might be right for
Glabellar Frown Lines
Allergan 40
Early research (Phase 1)Study completedNCT06834789
What this trial is testing

Assess the Adverse Events of Intramuscular Injections of AGN-151586 and OnabotulinumtoxinA in Adult Participants for the Change of Glabellar Lines (GL)

Who this might be right for
Glabellar Lines
AbbVie 132
Large-scale testing (Phase 3)Study completedNCT05248867
What this trial is testing

Assess Adverse Events and Change in Disease Activity of Intramuscular AGN-151586 Injection in Adult Participants With Glabellar Lines

Who this might be right for
Glabellar Lines
AbbVie 638
Large-scale testing (Phase 3)Study completedNCT05059587
What this trial is testing

Study to Evaluate the Efficacy and Safety of MBA-P01 in Subjects With Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Medytox Korea 318
Large-scale testing (Phase 3)Study completedNCT01224015
What this trial is testing

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines

Who this might be right for
Facial RhytidesCrow's Feet LinesGlabellar Lines
Allergan 684
Testing effectiveness (Phase 2)Study completedNCT04259086
What this trial is testing

Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Upper Facial Lines

Who this might be right for
Upper Facial Lines (Glabellar Lines, Forehead Lines, & Lateral Canthal Lines)
Revance Therapeutics, Inc. 48
Large-scale testing (Phase 3)Study completedNCT05248880
What this trial is testing

Assess Adverse Events and Change in Disease Activity of Intramuscular AGN-151586 Injection in Toxin-Naïve Adult Participants With Glabellar Lines

Who this might be right for
Glabellar Lines
Allergan 309
Large-scale testing (Phase 3)Study completedNCT01791920
What this trial is testing

To Evaluate the Safety and Efficacy of Botulax® Are Not Inferior to Those of Botox® in the Treatment of Glabellar Lines

Who this might be right for
Skin Aging
Hugel 262
Large-scale testing (Phase 3)Study completedNCT01447342
What this trial is testing

Evaluate the Safety and Effectiveness of the Cryo-Touch II Device for the Treatment of Forehead and/or Glabellar Lines

Who this might be right for
Facial WrinklesSkin Aging
Pacira Pharmaceuticals, Inc 54
Large-scale testing (Phase 3)Study completedNCT06585696
What this trial is testing

Clinical Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A for Injection (CU-20101)

Who this might be right for
Glabellar Frown Lines
Cutia Therapeutics（Wuxi）Co.,Ltd 554
Large-scale testing (Phase 3)Study completedNCT04157686
What this trial is testing

MT10109L in the Long-term, Open-label Treatment of Glabellar Lines (GL) and Lateral Canthal Lines (LCL)

Who this might be right for
Glabellar LinesLateral Canthal Lines
Medy-Tox 957
Large-scale testing (Phase 3)Study completedNCT00694148
What this trial is testing

Safety and Efficacy of NT 201, Free of Complexing Proteins, in the Treatment of Glabellar Frown Lines

Who this might be right for
Healthy
Merz Pharmaceuticals GmbH 108
Very early researchUnknownNCT04715048
What this trial is testing

Split-Face Study Comparing Botox and Jeuveau in Treating Glabellar Lines

Who this might be right for
Glabellar Frown Lines
University of Southern California 20
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation